ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,621Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 54

$686K Total Retail Price of All Prescriptions

Rank: 2 out of 54

516 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 516 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 12,238 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $140 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 795 738 1 18
FUROSEMIDE 718 710 2 8
AMLODIPINE BESYLATE 626 609 3 10
SIMVASTATIN 569 553 4 9
METOPROLOL SUCCINATE 557 557 5 17
OMEPRAZOLE 453 432 6 4
WARFARIN SODIUM 439 439 7 22
POTASSIUM CHLORIDE 354 354 8 30
LISINOPRIL 335 319 9 7
HYDROCODONE-ACETAMINOPHEN 271 266 S3 10 5
ATORVASTATIN CALCIUM 266 251 11 12
LOSARTAN POTASSIUM 235 231 12 31
METOPROLOL TARTRATE 207 201 13 24
FLUOXETINE HCL 177 173 14 59
HYDROCHLOROTHIAZIDE 169 164 15 44
QUINAPRIL HCL 162 158 16 79
ZOLPIDEM TARTRATE 154 144 17 32
ALENDRONATE SODIUM 153 153 18 19
SPIRONOLACTONE 152 150 19 41
VERAPAMIL ER 143 126 20 85
CRESTOR 142 142 21 39
METFORMIN HCL 135 135 22 90
AZITHROMYCIN 130 120 23 96
RAMIPRIL 120 107 24 99
PREDNISONE 119 119 25 2
BYSTOLIC 105 98 26 57
CELEBREX 105 105 26 46
TAMSULOSIN HCL 96 95 28 11
CLOPIDOGREL 93 86 29 14
DILTIAZEM ER 88 83 30 115
ALLOPURINOL 82 82 31 44
DIOVAN 79 79 32 78
NITROGLYCERIN PATCH 79 76 32 91
METFORMIN HCL ER 75 73 34 124
CIPROFLOXACIN HCL 74 73 35 40
PLAVIX 74 74 35 25
ENALAPRIL MALEATE 69 63 37 134
LOSARTAN-HYDROCHLOROTHIAZIDE 69 69 37 134
ADVAIR DISKUS 69 68 37 134
EXELON 65 65 40 142
ZETIA 65 61 40 71
NEXIUM 60 48 42 147
BENICAR 57 57 43 151
LIPITOR 56 50 44 83
DONEPEZIL HCL 53 53 45 33
AMOXICILLIN 50 50 46 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.